Our innovation, product development and commercialisaton services are designed to support through during the entire product development journey to help you de-risk projects and maximimise the probability of success.
A summary of our most popular services is provided below. We also regularly conduct bespoke projects for out clients, so please do not hesitate to contact us to informally discuss how we might be able to help.
Our Services
We can help you develop your innovation/ product development strategy and support you in understanding markets, how to identify opportunities and how to convert these into product development opportunities. This can be in the form of training, in house workshops or specific projects
Market, competitor and Technology reports are frequently commissioned to understand the landscape and are designed and scoped to understand the specific needs of the client. Typically, they either have a market or technology emphasis (or a mixture of both) and provide information on competitor solutions (e.g., technology segmentation, product positioning and claims) (either in market, near to market or early stage), and can be scoped to include information on market size and segmentation, patient pathways and clinical guidelines and can include an overview of regulatory and reimbursement considerations.
Companies use market/ competitor and technology analysis to make Go/No decisions with regard to investment decisions, use such reports as a means to identify new technologies or companies to acquire via licensing or acquisition activities or commercial partnerships or simply use the analysis to improve product design and to ensure product differentiation.
One of the key reasons why medical products fail in the market place is that the value proposition has not been developed early enough to influence further development work and often results in non-optimal claims being defined and poor clinical trial design that does not gather the right evidence to improve the probability of adoption.
Medilink provides an early-stage value proposition service to align the product or service to quality indicators that govern flows of money and as such are highly useful in d developing evidence generation plans (which can be included as part of the value proposition) that feed into clinical trial design to ensure the right evidence if collected to support adoption and market penetration.
Medilink have developed the MediPath Innovation Roadmap™ to help our clients plan their innovation journey to reduce risk, accelerate the speed to market, maximise the probability of market success and enhance profitability.
Drawing on our extensive experience and understanding of best practice, our team of experts have created a new tool to ensure that all key activities and milestones are considered. MediPath™ gives a comprehensive breakdown of all commercial, technical, clinical and regulatory actions, along with the associated resources, costs and time to get a medical device to market. See here for more information.
Understanding the market and competitor landscape is essential for de-risking innovations, optimising product positioning and maximising commercial potential. However, presenting complex competitor landscapes in a clear, concise way for decision-makers can be challenging.
The Medilink Innovation Impact Matrix™, developed by our Innovation & Commercialisation team, is a proprietary tool that transforms complex market data into a clear, visual snapshot.
By categorising competitors into incremental, substantial, radical, and disruptive quadrants, it highlights the most relevant current and future threats, supports go / no-go decisions, and strengthens investment pitches.
Discover the Innovation Impact Matrix™
Testimonials
The Medilink Innovation and Commercialisation and Regulatory course was fantastic with relevant content bespoke to our request for training. The interactive content and innovation management tools will help us manage and optimise our portfolio. The learnings gained from this course have upskilled our entire team. Great course!
The contribution of the Medilink team has helped to establish the resources, costs and timelines for commercialisation, which has been invaluable in our R&D planning. Metlase look forward to working with the Medilink team in the future as the project progresses.”
Medilink conducted a thorough market and competitor assessment regarding the opportunities for ClotProtect’s small molecule to attenuate blood loss. The work was conducted with considerable insight including identifying types of clinical need, which could represent commercial opportunities. The assessment also analysed existing types of solution with their benefits and limitations including clinical risks. The report also included a list of top-level design requirements and an appraisal of how the technology might be differentiated from existing solutions. The work was important for the strategic direction of the formation of the University Spin out – ClotProtect Therapeutics Limited.
BioMin Technologies commissioned Medilink to author a Clinical Evaluation Report (CER) for a class IIB device technical file submission with a tight deadline and were delighted with both the quality and speed of the report. In fact, it’s the best overview and review of our product I have seen and we will use it for technical, marketing and other purposes. Many thanks to Medilink on a great job.
The Medilink Team produced a “lie of the land” assessment for us covering market opportunity, competitor analysis, regulatory and reimbursement considerations. This input has been hugely beneficial and has allowed us to make informed investment decisions and helped de-risk our future pipeline.
Haemoconcepts are developing a novel device and we required a greater understanding and segmentation of the market and a value proposition. Medilink helped us understand the size and value of the market and also prepared a preliminary value proposition that allowed us to understand the key metrics and value that our device can provide the NHS. Thanks, it was a great report.
Medilink produced an excellent commercialisation road map, documenting the product development process with key milestones and the documentation needed for commercial activities to reduce market risk and the technical documentation required for submission to the notified body. The report has provided clarity in the route to market and has allowed us to plan both the time and resources needs for a successful product launch.
International Exhibitions
Medical Fair China + REHACARE China
Suzhou, China
Medical Fair Asia
Singapore
Medical Fair India | September 2026
Mumbai, India
REHACARE
Düsseldorf, Germany
Abu Dhabi Future Health Summit
Abu Dhabi, UAE
MEDICA 2026
Düsseldorf, GermanyGet in Touch
"*" indicates required fields